Wedbush is removing Geron (GERN) from the firm’s Best Ideas List due to its investment price discipline. Wedbush has an Outperform rating on ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Hosted on MSN23h
Geron price target lowered to $4 from $6 at ScotiabankScotiabank lowered the firm’s price target on Geron (GERN) to $4 from $6 and keeps an Outperform rating on the shares. While the company’s Q4 ...
Gerdau S/A Ord 1.22% R$33.15B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback